1/14
Flashcards covering the pharmacology, peri-anaesthetic considerations, monitoring, and protocol improvements for a geriatric, obese brachycephalic dog undergoing gastrointestinal foreign body surgery.
Case 1 Patient Signalment and Presentation
A 9kg, 12-year-old, male neutered (MN) Pug dog presenting for gastro-intestinal foreign body removal with a body condition score (BCS) of 8/9 (morbidly obese).
Omeprazole
A proton pump inhibitor (PPI) administered at 1mg/kg slow IV that inhibits gastric acid secretion to decrease damage to the trachea and oesophagus if regurgitation occurs.
Maropitant
A neurokinin-1 (NK1) receptor antagonist/agonist agent administered at 1mg/kg slow IV that prevents substance P binding in the central and peripheral nervous system to reduce vomiting and alpha-2 agonist-induced nausea.
Methadone
A full mu-agonist opioid administered at 0.3mg/kg slow IV that binds mu receptors to prevent pain transmission; it provides analgesia and sedation for moderate-to-severe pain with a low incidence of vomiting.
Medetomidine
An alpha-2 adrenergic agonist administered at 1μg/kg (1mcg/kg) slow IV that provides sedation, muscle relaxation, and analgesia while reducing the requirement for maintenance anaesthetic agents.
Alfaxalone
A synthetic neuroactive steroid induction agent administered at 2mg/kg IV slowly to effect that binds GABAA receptors to induce unconsciousness and muscle relaxation with reduced apnoeic risk when titrated slowly.
Buprenorphine
A partial mu-agonist opioid administered postoperatively at 0.015mg/kg slow IV four hours after postoperative methadone, providing mild sedation and 6–8hours of analgesia.
Meloxicam
A non-steroidal anti-inflammatory drug (NSAID) administered at 0.1mg/kg SC once recovered from anaesthesia; it inhibits COX-2 enzymes to reduce prostaglandin synthesis, reaching peak absorption at 4hours.
Maintenance Agent (Case 1)
Inhalational isoflurane mixed with 100% oxygen delivered to effect.
Pre-oxygenation Requirement
The administration of oxygen for a minimum of 10minutes prior to induction to minimize hypoxaemia during potential apnoea or difficult intubation in brachycephalic patients.
Atelectasis Risk in Obese Patients
Alveolar collapse impairing ventilation caused by morbid obesity (BCS 8/9) and prolonged recumbency during surgery where the patient cannot be turned.
Cardiovascular Depression from Medetomidine
A decrease in cardiac output and vascular perfusion requiring close monitoring with ECG, Doppler, stethoscope, CRT, and mucous membrane colour, especially in geriatric (12-year-old) patients.
Brachycephalic Extubation Protocol
The practice of leaving the endotracheal (ET) tube in place for as long as safely possible during recovery until the patient is awake and actively protecting its own airway.
Two-Dose Omeprazole Protocol Improvement
A strategy of administering omeprazole both the night before and 3hours prior to surgery to significantly neutralise gastric acidity compared to a single dose.
Local Anaesthetic Multimodal Improvement
The addition of local anaesthesia to the protocol to provide multimodal analgesia, smooth anaesthesia, and lower general anaesthetic drug requirements.